Medpace Holdings Inc

MEDP

Equity

ISIN null / Valor 33038552

NASDAQ (2026-03-26)

USD 466.60-0.04%

Medpace Holdings Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Medpace Holdings Inc. is a full-service clinical contract research organization (CRO) that specializes in providing comprehensive research and development services for the biotechnology, pharmaceutical, and medical device industries. With over three decades of experience, Medpace adopts a high-science, disciplined operating approach that emphasizes regulatory and therapeutic expertise across all major therapeutic areas. The company distinguishes itself through its collaborative teams of medical, operational, and regulatory experts who possess deep knowledge and insights into specific diseases and patient demographics targeted by clinical trials. Medpace's extensive experience also facilitates strong relationships with Key Opinion Leaders, Principal Investigators, and high-performing sites, which in turn helps to accelerate the clinical development process. The organization offers a wide range of services, including global cardiac safety and imaging through its Medpace Core Labs, as well as comprehensive CRO services supported by wholly-owned Central Laboratories, Bioanalytical Lab, Imaging Core Lab, ECG Core Lab, and a Phase I Unit. These services are integrated with a Clinical Trial Management System to streamline clinical trials, enhancing efficiency and productivity for biotech companies seeking to expedite the development of medical therapeutics.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

46.9%1Y

156%3Y

181%5Y

Performance

59.4%1Y

47.6%3Y

48.4%5Y

Volatility